Ryan Sun

3.6k total citations
60 papers, 546 citations indexed

About

Ryan Sun is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ryan Sun has authored 60 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Ryan Sun's work include Cancer Genomics and Diagnostics (8 papers), Genetic Associations and Epidemiology (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). Ryan Sun is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Genetic Associations and Epidemiology (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). Ryan Sun collaborates with scholars based in United States, China and Canada. Ryan Sun's co-authors include Xihong Lin, Lili Wu, Kanwal Raghav, Lu Yang, Ping Yin, Steven Zimmerly, Hongfei Zhou, David C. Christiani, Shirley Hui and Gary D. Bader and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Journal of the American Statistical Association.

In The Last Decade

Ryan Sun

52 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Sun United States 14 232 153 103 96 88 60 546
Caroline Clark United Kingdom 14 188 0.8× 256 1.7× 106 1.0× 79 0.8× 206 2.3× 30 668
Vincenzo Nardini Italy 14 175 0.8× 74 0.5× 65 0.6× 22 0.2× 127 1.4× 31 519
Rikke Hjortebjerg Denmark 16 225 1.0× 42 0.3× 97 0.9× 71 0.7× 24 0.3× 37 610
Valerie Pestinger United Kingdom 10 211 0.9× 59 0.4× 73 0.7× 58 0.6× 46 0.5× 13 578
Feng Guo China 16 228 1.0× 319 2.1× 45 0.4× 137 1.4× 179 2.0× 59 723
Pilar Mur Spain 15 188 0.8× 166 1.1× 53 0.5× 175 1.8× 62 0.7× 37 648
Zlatko Marušić Croatia 14 118 0.5× 180 1.2× 42 0.4× 54 0.6× 110 1.3× 55 505
Bo Yu China 14 303 1.3× 65 0.4× 83 0.8× 56 0.6× 45 0.5× 75 695
Dario Esposito Italy 14 91 0.4× 139 0.9× 156 1.5× 19 0.2× 227 2.6× 37 552
Xiaoling Weng China 16 382 1.6× 160 1.0× 40 0.4× 187 1.9× 91 1.0× 31 696

Countries citing papers authored by Ryan Sun

Since Specialization
Citations

This map shows the geographic impact of Ryan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Sun more than expected).

Fields of papers citing papers by Ryan Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Sun. The network helps show where Ryan Sun may publish in the future.

Co-authorship network of co-authors of Ryan Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Sun. A scholar is included among the top collaborators of Ryan Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Sun. Ryan Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Ryan, et al.. (2025). Using Computational Models to Detect Autistic Tendencies for Children from their Story Book Narratives. Multimedia Tools and Applications. 84(6). 3175–3196.
2.
Grippin, Adam, N. Li, Christian Braun, et al.. (2025). LBA54 SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade. Annals of Oncology. 36. S1598–S1598.
3.
Mach, Kathleen E., Hubert Lau, Ryan Sun, et al.. (2025). Disrupting Biofilms on Human Kidney Stones–A Path Toward Reducing Infectious Complications During Stone Surgery. Advanced Healthcare Materials. 14(17). e2403470–e2403470.
4.
Grippin, Adam, Nan Li, Ryan Sun, et al.. (2025). 419 SARS-CoV-2 mRNA vaccines sensitize immunologically ‘cold’ tumors to immune checkpoint blockade. Regular and Young Investigator Award Abstracts. A475–A475.
5.
Yu, Changyuan, Meijia Zhang, Yichen Li, et al.. (2024). Design and implementation of a radiomic-driven intelligent dental hospital diversion system utilizing multilabel imaging data. Journal of Translational Medicine. 22(1). 1123–1123. 1 indexed citations
6.
Lin, Lu, et al.. (2024). Virtual Context Enhancing Jailbreak Attacks with Special Token Injection. 11843–11857. 2 indexed citations
7.
Sun, Ryan, Nicole Zhang, Leylah Drusbosky, et al.. (2024). Characterization of mutational signatures demonstrating adaptive mutability post anti-EGFR therapy in a real-world metastatic colorectal cancer cohort.. Journal of Clinical Oncology. 42(16_suppl). 3545–3545. 1 indexed citations
8.
Bahrambeigi, Vahid, Jaewon J. Lee, Vittorio Branchi, et al.. (2024). Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-Specific Transcriptome and Molecular Subtype. Cancer Research. 84(10). 1719–1732. 6 indexed citations
9.
Yang, Tianzhong, et al.. (2024). Identification of Pancreatic Cancer Germline Risk Variants With Effects That Are Modified by Smoking. JCO Precision Oncology. 8(8). e2300355–e2300355. 1 indexed citations
10.
Hornstein, Nicholas J., Mohammad A. Zeineddine, Andrew J. Pellatt, et al.. (2024). Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma. Cancer Research Communications. 4(5). 1363–1368. 3 indexed citations
11.
Lin, Timothy A., Zachary R. McCaw, Joseph Abi Jaoude, et al.. (2024). Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation. Clinical Cancer Research. 30(20). 4791–4799. 4 indexed citations
12.
Alvarez, P, et al.. (2024). Lifetime extension of optically stimulated luminescent dosimeters above 10 Gy. Radiation Measurements. 171. 107063–107063. 2 indexed citations
13.
Napolitano, Stefania, Aparna R. Parikh, Jason T. Henry, et al.. (2023). Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing. JCO Precision Oncology. 7(7). e2300228–e2300228. 1 indexed citations
14.
Chu, Fuliang, Jingjing Cao, Jingwei Liu, et al.. (2023). Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas. Journal for ImmunoTherapy of Cancer. 11(11). e007515–e007515. 9 indexed citations
15.
McCaw, Zachary R., Sheila M. Gaynor, Ryan Sun, & Xihong Lin. (2022). Leveraging a Surrogate Outcome to Improve Inference on a Partially Missing Target Outcome. Biometrics. 79(2). 1472–1484. 1 indexed citations
16.
Parseghian, Christine M., Ryan Sun, Stefania Napolitano, et al.. (2022). Resistance Mechanisms to Anti–Epidermal Growth Factor Receptor Therapy in RAS/RAF Wild-Type Colorectal Cancer Vary by Regimen and Line of Therapy. Journal of Clinical Oncology. 41(3). 460–471. 41 indexed citations
17.
Raghav, Kanwal, Fang‐Shu Ou, Alan P. Venook, et al.. (2022). Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance). Journal of Clinical Oncology. 41(3). 472–478. 25 indexed citations
18.
Alhalabi, Omar, Ryan Sun, Elshad Hasanov, et al.. (2021). Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases. npj Breast Cancer. 7(1). 28–28. 5 indexed citations
19.
Yam, Clinton, Gaiane M. Rauch, Meghan Karuturi, et al.. (2020). A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer. Investigational New Drugs. 39(2). 509–515. 24 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Clark Breakdown of academic impact, for papers by Vincenzo Nardini Breakdown of academic impact, for papers by Rikke Hjortebjerg Breakdown of academic impact, for papers by Valerie Pestinger Breakdown of academic impact, for papers by Feng Guo Breakdown of academic impact, for papers by Pilar Mur Breakdown of academic impact, for papers by Zlatko Marušić Breakdown of academic impact, for papers by Bo Yu Breakdown of academic impact, for papers by Dario Esposito Breakdown of academic impact, for papers by Xiaoling Weng
Rankless by CCL
2026